Sn-125, also known as Tin-125, is a radioactive isotope of the element tin. It has a half-life of approximately 9.64 days and decays into tellurium-125.
Sn-125 is primarily used in medical applications, specifically in brachytherapy. It is used to treat prostate cancer by delivering targeted radiation directly to the tumor.
When used correctly and in controlled settings, Sn-125 is considered safe. However, it is a radioactive material and should be handled with caution and proper safety protocols.
Sn-125 is produced through the process of neutron activation, where stable tin-124 is irradiated with neutrons in a nuclear reactor.
The potential risks of using Sn-125 include radiation exposure, contamination, and improper handling of the radioactive material. It is important to follow proper safety protocols and regulations when using Sn-125.